AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,236,500 | -12.6% | 454,000 | 0.0% | 0.61% | -11.6% |
| Q2 2023 | $12,857,280 | +23.3% | 454,000 | 0.0% | 0.69% | +55.8% |
| Q1 2023 | $10,428,380 | -45.8% | 454,000 | -33.8% | 0.44% | -45.5% |
| Q4 2022 | $19,256,478 | -29.0% | 685,772 | -28.5% | 0.81% | -28.2% |
| Q3 2022 | $27,127,000 | -47.3% | 959,214 | -58.7% | 1.13% | -42.5% |
| Q2 2022 | $51,474,000 | +50.2% | 2,321,800 | +97.2% | 1.96% | +86.9% |
| Q1 2022 | $34,273,000 | -11.4% | 1,177,374 | 0.0% | 1.05% | +39.8% |
| Q4 2021 | $38,700,000 | -36.1% | 1,177,374 | -10.2% | 0.75% | -26.6% |
| Q3 2021 | $60,537,000 | +11.2% | 1,311,748 | +32.8% | 1.02% | +25.3% |
| Q2 2021 | $54,419,000 | -2.5% | 987,456 | -8.7% | 0.81% | -1.5% |
| Q1 2021 | $55,841,000 | +577.2% | 1,081,347 | +468.2% | 0.83% | +600.0% |
| Q4 2020 | $8,246,000 | – | 190,300 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |